Bicycle Therapeutics PLC Share Price Today: Live Updates & Key Insights
Bicycle Therapeutics PLC share price today is $3.92, up -6.97%. The stock opened at $4.16 against the previous close of $4.16, with an intraday high of $4.16 and low of $3.88.
Bicycle Therapeutics PLC Share Price Chart
Bicycle Therapeutics PLC
Bicycle Therapeutics PLC Share Price Performance
Bicycle Therapeutics PLC Institutional Holdings
Bicycle Therapeutics PLC Market Status
Bicycle Therapeutics PLC Fundamentals
Market Cap 293.91 M
PB Ratio 0.5289
PE Ratio 0.0
Enterprise Value -250.93 M
Total Assets 717.60 M
Volume 572862
Bicycle Therapeutics PLC Company Financials
About Bicycle Therapeutics PLC & investment objective
Company Information Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment of high nectin-4 expressing tumors; nuzefatide pevedotin (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expressing tumor; BT7480, a Bicycle tumor-targeted immune cell agonist molecule, which is in phase I/II targeting nectin-4 and agonizing CD137; and BT1702, a theranostic BRC molecule targeting MT1-MMP for which IND-enabling activities are ongoing. In addition, it develops Novel CNS targets, which is in preclinical trial targeting CNS disease; Novel neuromuscular targets, which is in preclinical trial targeting neuromuscular disease; and programs that are in preclinical trial targeting radiopharmaceutical. Further, the company collaborates with biopharmaceutical companies and organizations to develop programs in therapeutic areas. It has collaboration and license agreement with Bayer Consumer Care AG; Novartis Pharma AG; Ionis Pharmaceuticals, Inc.; Genentech, Inc; and AstraZeneca AB. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom.
Organisation Biotechnology
Employees 288
Industry Biotechnology
CEO Dr. Kevin Lee M.B.A., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Bicycle Therapeutics PLC FAQs
What is the share price of Bicycle Therapeutics PLC today?
The current share price of Bicycle Therapeutics PLC is $3.92.
Can I buy Bicycle Therapeutics PLC shares in India?
Yes, Indian investors can buy Bicycle Therapeutics PLC shares by opening an international trading and demat account with Motilal Oswal.
How to buy Bicycle Therapeutics PLC shares in India?
You can easily invest in Bicycle Therapeutics PLC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Bicycle Therapeutics PLC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Bicycle Therapeutics PLC.
Can I buy fractional shares of Bicycle Therapeutics PLC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Bicycle Therapeutics PLC?
Bicycle Therapeutics PLC has a market cap of $293.91 M.
In which sector does Bicycle Therapeutics PLC belong?
Bicycle Therapeutics PLC operates in the Biotechnology sector.
What documents are required to invest in Bicycle Therapeutics PLC stocks?
To invest, you typically need:
What is the PE and PB ratio of Bicycle Therapeutics PLC?
The PE ratio of Bicycle Therapeutics PLC is N/A and the PB ratio is 0.53.